drug

US Attorney for the Southern District of New York Jay Clayton said in the statement: “As the indictment lays bare, the Sinaloa cartel, and other drug trafficking organisations like it, would not operate as freely or successfully without corrupt politicians and law enforcement officials on their payroll”.

April 27 (UPI) — The U.S. military has killed another three men in its latest attack targeting suspected drug-trafficking boats in the eastern Pacific, U.S. Southern Command announced late Sunday.

It was the 54th strike in the Trump administration’s violent anti-drug smuggling campaign that has killed at least 185 people since early September, according to UPI’s tally of publicly released data. At least 57 boats have been destroyed in the attacks in the eastern Pacific and Caribbean.

SOUTHCOM has announced each strike on social media, accompanied by a short black-and-white aerial video of the attack, showing the boat erupting in flames.

As with the previous strikes, SOUTHCOM said in a statement that the boat it attacked Sunday “was transiting along known narco-trafficking routes in the eastern Pacific and was engaged in narco-trafficking operations.”

The Trump administration claims the vessels are operated by 10 drug cartels and gangs that President Donald Trump has designated as terrorist organizations since returning to office, but has yet to provide evidence.

Trump argues the use of deadly force is warranted as the United States is in “armed conflict” with those organizations, but his administration has come under mounting accusations of conducting extrajudicial killings.

The strikes have been repeatedly condemned and their legality questioned by Democrats and human rights organizations, who accuse the Trump administration of violating international and maritime law by using the military to conduct law enforcement drug operations.

Ben Saul, the United Nations’ special rapporteur on counterterrorism and human rights, chastised the Trump administration last month for “responding with lawless violence that flagrantly violates human rights, in its phony war on so-called narco-terrorism.”

The attacks are not permissible law enforcement action in self-defense, authorized under the law of the sea, in national self-defense or under international humanitarian law, he said.

On Thursday, 125 humanitarian, human rights, peacebuilding and other related organizations from around the world called on all states to “immediately cease or refrain from supporting U.S. extrajudicial killings.”

The letter warned that states could be held legally responsible for aiding or assisting the United States by sharing intelligence as well as providing access to military bases and logistical support with the U.S. military.

The groups argue that the consequences of these killings are being felt throughout the hemisphere.

“Families awaiting the return of their loved ones may never know what happened to them and have no access to recourse,” the organizations said in their open letter.

“Coastal communities have witnessed human remains washing up on shore and fear for their lives when they trade and fish, sowing psychological trauma and undermining livelihoods.”

The Trump administration’s historic move to reclassify state-licensed medical marijuana as a less-dangerous drug was cheered by some advocates but for others, it fell far short for the thousands still incarcerated on federal cannabis-related convictions.

The executive order, which acting Atty. Gen. Todd Blanche signed Thursday, does not address current penalties for possessing and selling marijuana or those jailed with yearslong sentences.

“While this is a victory, the fight is far from over,” said Jason Ortiz, director of strategic initiatives for the Last Prisoner Project, a nonprofit focused on cannabis criminal justice reform.

Proponents of legalizing marijuana as well as overhauling prison sentencing say this order, which does not completely decriminalize the drug, benefits only cannabis researchers, growers and others in Big Weed. Meanwhile, thousands — many of whom are people of color — are stuck serving harsh sentences for marijuana-related offenses. Or they have served their time but having a conviction on their record has made life difficult.

Now, advocates are calling on Congress and state lawmakers to take concrete steps to ensure those with marijuana-related convictions receive fair treatment or be forgiven altogether.

Prisoners and their families look for hope

Blanche’s order reclassifies state-licensed medical marijuana as a less-dangerous drug. The major policy shift, which both Presidents Obama and Joe Biden had considered, means cannabis won’t be grouped with drugs like heroin.

But it does not legalize marijuana for medical or recreational use. It shifts licensed medical marijuana from Schedule I — reserved for drugs without medical use and with high potential for abuse — to the less strictly regulated Schedule III. This will likely give licensed medical marijuana operators and cannabis researchers a major tax break and less stringent barriers to doing normal business.

Virtually no one imprisoned at the federal level is there solely for marijuana possession. But many are there for large-scale possession, trafficking offenses or both.

Hector Ruben McGurk, 66, has been serving life without the possibility of parole since 2007 for transporting thousands of pounds of marijuana and money laundering. He is currently imprisoned in Beaumont, Texas, over 800 miles from his son’s El Paso home. His incarceration has been hard on his son, said McGurk’s daughter-in-law, Ferna Anguiano. And the distance makes visits logistically difficult.

So it’s tempting to see this order as a glimmer of hope, given that the family believes McGurk’s punishment far outweighs his crimes. But Anguiano has no idea how to navigate lobbying for his release.

“His release date is death,” Anguiano said. “I mean, we see all this stuff on the news — bigger cases, fatal cases — and people are going in and out of prison and coming out to their families.”

They try to keep in touch through phone calls and a prison texting service. They’re concerned about McGurk’s health and his diabetes management. It would be a dream come true for him to come home.

“He deserves a second chance,” Anguiano said. “Yes, it was a poor decision he did in his lifetime. He was younger. But he is not a bad person. I think it’s fair to say he has served enough time for it.”

It’s not clear whether punishments would be different had marijuana always been scheduled differently, drug policy experts say.

“In addition to schedule-specific penalties, there are marijuana-specific penalties that have nothing to do with the schedule,” said Cat Packer, director of drug markets and legal regulation at the nonprofit Drug Policy Alliance. “Even if marijuana were to be moved to Schedule V, those criminal penalties would still exist and there are mandatory minimums for simple possession.”

Racial disparities exist in convictions and Big Weed

Destigmatizing marijuana has long been an issue for both political parties. Obama commuted the sentences of about 1,900 federal prisoners, almost all of whom were incarcerated for nonviolent drug crimes. Biden pardoned 6,500 people convicted of use and simple possession of marijuana on federal lands and in the District of Columbia. President Trump’s administration has taken far fewer drug clemency actions and does not have an overarching policy directing such actions.

“What many people on the right and the left would like is to move marijuana from this ‘just as bad as heroin’ category and to just sort of de-schedule it entirely,” said Marta Nelson, director of sentencing reform at the Vera Institute of Justice. “Regulate it like you do alcohol or tobacco.”

Studies show Black Americans are roughly 3.7 to 4 times more likely to be arrested for marijuana possession than white Americans, despite usage rates being roughly the same across racial groups. Federal-level marijuana cases are pretty small today, but those serving sentences for federal drug offenses are overwhelmingly Hispanic and Black, according to Justice Department and Bureau of Justice Statistics data.

The racial disparity with drug convictions is reminiscent of 2010 legislation Obama signed reducing the gap between mandatory sentences for crack cocaine versus powder cocaine. In 2018, Trump made it apply retroactively.

Because business owners with state medical marijuana licenses are predominantly white, the tax relief created by the rescheduling will also likely give a leg up to mostly white businesses, Packer said. A lot of equity programs won’t apply.

“This is going to, in my mind, widen the gap, the financial disparities, the business disparities that currently exist between Black and brown, Latino and white owners in the cannabis industry because licenses were not distributed equitably,” Packer said.

Possible next steps for marijuana convictions

In theory, Trump could issue a blanket pardon like he did for Jan. 6 rioters. But Nelson thinks that is highly doubtful.

“Having marijuana convictions on the record for things like mass immigration enforcement is helpful to the administration,” Nelson said.

An impactful next step would be for Congress to outline very comprehensive legislation addressing existing marijuana-related convictions, expungements and industry regulations, she added.

The Last Prisoner Project and other organizations are planning to renew a dialogue with federal lawmakers, including the Congressional Cannabis Caucus, which includes Democratic Rep. Ilhan Omar of Minnesota and Republican Rep. David Joyce of Ohio. They will also continue to lobby for Trump to conduct a large-scale act of commutation and clemency.

Advocates are also hoping Trump’s order will prompt every state to rethink their marijuana classification and penalties.

“It is imperative that every state review their situation, as a lot of their controlled substances at the state level are tied to the federal government,” Ortiz said. “We’re gonna see other states that are going to need a little help from the public to remind them what the right thing to do is.”

Tang writes for the Associated Press.

April 23 (UPI) — On Thursday, President Donald Trump announced a new drug price deal with Regeneron, the latest to agree to the “most favored nation” price policy the White House has pushed since last year.

The price deals involve voluntary price cuts by manufacturers for drugs sold to the public and the government through the TrumpRx website. In return, the manufacturers get breaks on Trump’s tariffs and other perks.

In addition, Regeneron also announced Thursday that the Federal Food and Drug Administration has approved Otarmeni, a gene therapy for genetic hearing loss. The company said the therapy would be available free in the United States.

The company is the last of the 17 the administration sought for the price policy, but officials said that more will follow. Smaller companies may also look to make deals.

“It’s not the finish line,” said Chris Klomp of the Department of Health and Human Services, who was chief negotiator on the deals, the Washington Post reported.

For the most part, the discounts do not affect people with private insurance or those on Medicaid, Axios reported. They do affect Medicaid drug prices and those buying through the TrumpRx website.

Trump called the program “the biggest price reduction in drugs in history.”

However, some have said the prices are higher through TrumpRx than through other sources, the Washington Post reported. Some lawmakers also are calling for the confidential terms of the agreements to be released, a subject that came up in hearings this week with Health and Human Service Secretary Robert F. Kennedy Jr, who has not committed to such a release.

WASHINGTON — President Trump’s acting attorney general on Thursday signed an order reclassifying state-licensed medical marijuana as a less-dangerous drug, a major policy shift long sought by advocates who said cannabis should never have been treated like heroin by the federal government.

The order signed by Todd Blanche does not legalize marijuana for medical or recreational use under federal law. But it does change the way it’s regulated, shifting licensed medical marijuana from Schedule I — reserved for drugs without medical use and with high potential for abuse — to the less strictly regulated Schedule III. It also gives licensed medical marijuana operators a major tax break and eases some barriers to researching cannabis.

The Trump administration also said it was jump-starting the process for reclassifying marijuana more broadly, setting a hearing to begin in late June.

Trump told his administration in December to work as quickly as possible to reclassify marijuana. On Saturday, as the Republican president signed an unrelated executive order about psychedelics, he seemed to express frustration that it was taking so long.

Blanche said Thursday that the Department of Justice was “delivering on President Trump’s promise” to expand Americans’ access to medical treatment options. “This rescheduling action allows for research on the safety and efficacy of this substance, ultimately providing patients with better care and doctors with more reliable information,” he said in a statement.

What the marijuana reclassification order does

Blanche’s action largely legitimizes medical marijuana programs in the 40 states that have adopted them. It sets up an expedited system for state-licensed medical marijuana producers and distributors to register with the U.S. Drug Enforcement Administration.

It makes clear that cannabis researchers won’t be penalized for obtaining state-licensed marijuana or marijuana-derived products for use in their work, and it grants state-licensed medical marijuana companies a windfall by allowing them, for the first time, to deduct business expenses on their federal taxes.

Any marijuana-derived medicine approved by the Food and Drug Administration is similarly listed in Schedule III, it said.

Since 2015, Congress has prohibited the Justice Department from using its resources to shut down state-licensed medical marijuana systems. But the order nevertheless represents a major policy shift for the U.S. government, which has continued its long-standing marijuana prohibition — dating to the Marihuana Tax Act of 1937 — even as nearly all the states have approved cannabis use in some form.

Two dozen states plus Washington, D.C., have authorized adult recreational use of marijuana, 40 have medical marijuana systems, and eight others allow low-THC cannabis or CBD oil for medical use. Only Idaho and Kansas ban marijuana outright.

The regulation of medical marijuana has come a long way since California became the first state to adopt it in 1996, Blanche wrote.

“Today the vast majority of States maintain comprehensive licensing frameworks governing cultivation, processing, distribution, and dispensing of marijuana for medical purposes,” Blanche wrote. “Taken as a whole, they demonstrate a sustained capacity to achieve the public-interest objectives … including protecting public health and safety and preventing the diversion of controlled substances into illicit channels.”

The president of the American Trade Assn. for Cannabis and Hemp, Michael Bronstein, called it “the most significant federal advancement in cannabis policy in over 50 years.”

“This action recognizes what Americans have long known, cannabis is medicine,” he said in a written statement.

Critic calls the order ‘a tax break to Big Weed’

The Trump administration’s decision drew derision from marijuana legalization opponent Kevin Sabet, the chief executive of Smart Approaches to Marijuana. Sabet said that while marijuana research is necessary, “there are many ways to increase our knowledge without giving a tax break to Big Weed and sending a confusing message about marijuana’s harms to the American public.”

“With this move, we are now confronted with the most pro-drug administration in our history,” Sabet said in a text message. “Policy is now being dictated by marijuana CEOs, psychedelics investors, and podcasters in active addiction.”

Marijuana or marijuana-derived products that are not distributed through a state medical marijuana program will continue to be classified in Schedule I.

Schedule III drugs are defined as having moderate to low potential for physical and psychological dependence. Some critics of the industry have suggested that legalization in the states has led to stronger and stronger cannabis products, which need to be researched rather than categorized less strictly than before.

The efforts to reclassify marijuana

The Justice Department under President Biden had proposed to reclassify marijuana, eliciting nearly 43,000 formal public comments. The DEA was still in the review process when Trump succeeded Biden, and Trump ordered that process to move along as quickly as legally possible.

Blanche’s order sidestepped the review process by relying on a provision of federal law that allows the attorney general to determine the appropriate classification for drugs that the U.S. must regulate pursuant to an international treaty.

It was unclear how the order might affect operations in states where licensed recreational marijuana shops also sell to medical patients. In Washington state, which in 2012 became one of the first states to legalize the adult use of marijuana, 302 of 460 licensed stores have endorsements allowing them to sell tax-free cannabis products to registered patients.

Many Republicans oppose loosening marijuana restrictions. More than 20 Republican senators, several of them staunch Trump allies, signed a letter last year urging the president to keep the current standards.

Trump has made his crusade against other drugs, especially fentanyl, a feature of his second term, ordering U.S. military attacks on Venezuelan and other boats the administration insists are ferrying drugs. He signed another executive order declaring fentanyl a weapon of mass destruction.

Richer and Johnson write for the Associated Press. Johnson reported from Seattle.

It felt like the Olympics. Crowds cheering. The American flag standing tall above the bleachers. Trainers jumping with anticipation. A swimmer staring in disbelief at the clock after his final stroke. The Jumbotron announced: Kristian Gkolomeev — 20.89 seconds. A new world record in the 50-meter freestyle.

Well, kind of.

I’ve left out some details. There was only one swimmer. The crowd? Just doctors, trainers and filmmakers. This was not in an Olympic city nor an Olympic year, but in Greensboro, N.C., in 2025. And there were no iconic rings on the banners, just “Enhanced Games.”

Yes, Gkolomeev swam faster than César Cielo, the official record holder at the time (20.91 seconds). But he did it “enhanced” — a polite way to say that he used performance-enhancing drugs. At the Enhanced Games, doping isn’t punished. It’s required.

The concept, as described by the organization: “to create the definitive scientific, cultural and sporting movement that safely evolves mankind into a new superhumanity.”

Backed by investors such as Peter Thiel and Donald Trump Jr.’s 1789 Capital, the Enhanced Games embodies a techno-utopian ideal: athletes as canvases for chemical optimization, testing the limits of human health for a lot of money. Gkolomeev earned $1 million for his record.

So far, the competition has happened at one-off pop-up events. But in May, Las Vegas will host the first full-scale Enhanced Games, a four-day meet in swimming, track and field, and weightlifting. The group advertises a “potential prize purse of $7.5 million for just a single day of competition,” plus appearance fees.

Does it need to be said? Apparently yes: The Enhanced Games glorifies the risky use of enhancement drugs.

Steroids can harden arteries, elevate stroke risk, damage the liver and permanently alter hormone systems. They are not electrolyte tablets or a little preworkout creatine. If Lance Armstrong had been rewarded — rather than sanctioned — for doping, what would have happened to competitive cycling?

Fans — and especially kids — mimic their idols. As risky as the drugs are for athletes at the Enhanced Games, with its “medical commission” to give the illusion of safety, the substances are even more dangerous when used by people without medical supervision.

The games also expose the economic neglect that drives athletes toward such competition. As Benjamin Proud, the British silver medalist who recently joined the Enhanced Games, put it: “It would have taken me 13 years of winning a World Championship title in order to win what I could win in one race at these games.”

Indeed, the Enhanced Games might look like an easy way out. Only nine swimmers worldwide received prize money and performance bonuses above $75,000 in 2025, according to World Aquatics.

Investors clearly hope to make money off the games as well. The organization is moving closer to becoming a publicly traded company. The economics are not mysterious.

But the Enhanced Games are not just another sporting event. They are an arena for biomedical experimentation and should be regulated as such. The games should face limits similar to those imposed on other high-risk industries, including age restrictions and strict advertising rules.

We already know how to govern legal, profitable activities that carry serious health risks.

In the United States, that means oversight from the Food and Drug Administration and the Federal Trade Commission — bodies that regulate drug protocols and police misleading commercial claims. A steroid-based competition should not be treated as a sport but as a medical experiment and a marketing stunt.

Regulations on pharmaceutical advertising offer a useful model for the Enhanced Games. Prescription drugs are advertised every night on television, but only under strict rules. They require fair balance (content must present benefits and risks with comparable prominence, readability and duration) and a “major statement” of risks (most serious risks must be spoken aloud and not obscured by visuals or music).

Right now, when you play Gkolomeev’s “world-record” video on YouTube, a medical-risk warning appears for barely five seconds — then vanishes. If a cholesterol drug must audibly warn viewers of stroke risk, why shouldn’t a steroid-based competition do the same?

Enhanced Games content should be accompanied by clear warnings of the risks of performance-enhancing drugs and be clearly labeled, age-gated and distributed as high-risk content more akin to pornography than to a boxing match.

Prohibition is not the answer. Trying to shut down these games only fuels a controversy-driven brand. Just recently, the Enhanced Games sued organizations such as World Aquatics and the World Anti-Doping Agency, alleging antitrust violations and that blocking athletes from participating at the Enhanced Games is illegal. As those organizations fight back, they will be seeking to protect the integrity of mainstream sports, but they will also inadvertently be promoting the Enhanced Games.

If we want kids to admire clean athletes rather than those using banned drugs, the Las Vegas launch must not reach the world as a Super Bowl would. The Enhanced Games should not be televised or allowed to stream online to minors. Otherwise, Las Vegas, in May, risks becoming an unregulated public-health experiment mislabeled as a sporting event.

Fabricio Ramos dos Santos is a lawyer, entrepreneur and sports investor.

For disputed reasons, April 20, abbreviated to 420, has become a day to celebrate marijuana; even if this is nothing you mark on your calendar, the collective culture is bound to remind you.

Weed is not what it used to be, which is to say illegal everywhere. (State laws may differ, but the federal government still disapproves.) Stoners are no longer useful as a comedy device, while pot’s countercultural meaning has dissipated as it’s been absorbed into the mainstream. According to the CDC, some 60 million American reported using it in 2022. Snoop Dogg is a beloved media figure (and, somehow, an Olympics commentator). Seth Rogen co-owns a cannabis company, Houseplant, that also sells coffee, furniture and incense. The paper you are reading has published weed-themed gift guides.

Now, Hulu, wholly owned by the Walt Disney Company, is marking the day (Monday) with “4×20: Quick Hits,” a frisky anthology comprising four 20-minute documentaries on pot-related subjects, with family-friendly figure Jimmy Kimmel as an executive producer. It’s less about the drug itself than the arts, crafts and enterprises it has inspired. Given where we are now, it’s not surprising that there’s a historical bent to the films, a look back to earlier times — certainly worse for some of the people profiled, who were targeted by and battled with the law in pursuit of their businesses and dreams — but one they regard with a kind of amused nostalgia.

All the films are affectionate, most are light-hearted and often comical. One, Todd Kapostasy’s “Bong Voyage,” about the rise and fall and rise of artisanal glassblower Jason Harris, is narrated by one of his creations and includes such dumb puns as “fine piece of glass.” Directed by Brent Hodge, “Highly Unlikely” is an entertaining, straightforward reminiscence of the making of “Harold & Kumar Go to White Castle,” though it is less about the stoner themes than how the film broke stereotypes in making two little-known Asian actors, John Cho and Kal Penn, the film’s stars. The adorable “The Legend of Ganjasaurus Rex,” directed by Alex Ross Perry, and nearly the premise for a Christopher Guest movie, recounts an act of community filmmaking in the late ‘80s in pot-growing Humboldt County, wherein locals created a monster movie in a proxy war with the authorities, and its inspirational afterlife.

More serious in tone is Kyle Thrash‘s “High Times,” which looks at the history of the pot-centric magazine, its drug smuggling founder Tom Forçade and his suicide. More compelling perhaps is his friend, Yippie co-founder and lifelong cannabis activist Dana Beal, who frames the film; we see him in the nearly present day on trial for drug trafficking, having been stopped in Idaho with 56 pounds of raw marijuana, and also on the streets of New York leafleting passersby with his daughter to “help us legalize weed worldwide.”

Whether or not cannabis itself interests you, each of these mini-docs is capable of holding your attention for 20 minutes — assuming you’re capable from your end — and, being as brief as they are, may well send you to learn more. (I don’t imagine they will send you to smoke pot if you don’t — they didn’t work on me, anyway — and, who knows, might even make one less inclined.) You might finally watch “Harold & Kumar,” or find Garberville on a map, or look to see how things are going for Beal, or discover whether the same John Holmstrom who once edited High Times is the same person who founded Punk magazine and drew covers for the Ramones’ “Rocket to Russia” and “Road to Ruin” albums. (He is.) “Ganjasaurus Rex,” in its 90-minute full length, is itself online to see, and, for those who celebrate, I don’t suppose there’s a better day to watch it.

April 20 (UPI) — The U.S. military announced late Sunday that it has killed three men in its latest strike targeting a suspected drug-smuggling boat in the Caribbean.

Seventeen people have been killed in six strikes the U.S. Southern Command has carried out in little over a week, marking one of the deadliest publicly announced stretches of the Trump administration’s monthslong anti-drug smuggling operation.

As in previous strike announcements, SOUTHCOM released little information.

The attack occurred Sunday, targeting a boat operated by a designated terrorist organization in the Caribbean, SOUTHCOM said in a statement, without naming the organization or providing evidence.

“Intelligence confirmed the vessel was transiting along known narco-trafficking routes in the Caribbean and was engaged in narco-trafficking operations,” it said.

A 12-second, black-and-white clip of the strike posted to SOUTHCOM’s social media shows a boat moving across the ocean before disappearing in a large fiery explosion.

Since the first strike on Sept. 2, the U.S. military has killed at least 180 people, according to UPI’s tally of publicly released data. Fifty-five boats have been destroyed in the more than 50 strikes.

President Donald Trump argues that the use of deadly military force is warranted as the United States is in “armed conflict” with the 10 drug cartels and gangs he has designated as terrorist organizations since returning to the White House in January 2025.

The operation comes as the Trump administration seeks to expand its influence in the Western Hemisphere, including by using its military to dismantle what Trump has called “narco-terrorist networks.”

The strikes have been repeatedly condemned and their legality questioned by Democrats, rights groups, critics and United Nations experts, who accuse the Trump administration of violating international and maritime law over the use of the military to conduct law enforcement drug operations.

Last month, Ben Saul, the United Nations’ special rapporteur on counter-terrorism and human rights, lambasted the Trump administration over “its phony war on so-called narco-terrorism.”

“These serial extrajudicial killings gravely violate the right to life, which applies extraterritorially,” he said on March 13.

“The attacks were not in national self-defense, since the vessels were not engaged in any armed attack on the U.S. Drug trafficking is crime, not war.”

On Wednesday, the same day the U.S. military killed three people in a strike in the eastern Pacific, a group of Democrats, led by Rep. John Larson of Connecticut, filed six articles of impeachment against Defense Secretary Pete Hegseth, with one of the articles accusing him of violating the law of armed conflict over the strikes.

Larson accused Hegseth of abusing his position by ordering “our armed forces to strike boats in the Caribbean,” he said in a statement.

April 13 (UPI) — The Government of Colombia said Monday it will cull up to 80 hippos descended from animals illegally introduced by drug trafficker Pablo Escobar in the 1980s as part of a plan to control an invasive population that now exceeds 160 of the animals, environmental authorities reported.

The Minister of Environment and Sustainable Development of Colombia, Irene Vélez Torres, signed a circular establishing guidelines and targets for institutional coordination in the management and control of invasive hippos in the South American country.

“With this circular, we are advancing coordinated actions with regional corporations for the management of hippos in the country. Two key protocols are adopted: translocation and euthanasia,” she said on X.

This decision, whose implementation will begin in the second half of 2026, according to local media such as El Espectador, responds to the uncontrolled growth of these animals in the Magdalena Medio region. There, they have altered local ecosystems, affected water sources and generated risks for nearby communities.

The hippos were originally brought by Colombian drug lord Pablo Escobar to his private estate, Hacienda Nápoles. After he died in 1993, the animals were left without effective state control and began to reproduce in the wild.

They now represent one of the most unusual cases of invasive species in Latin America.

The environment minister said the government evaluated for years alternatives such as sterilization and international relocation, but none have been sufficient to contain population growth.

“This ministry has carried out enormous diplomatic efforts, and at this moment no country wants to take responsibility,” Vélez said in remarks to Blu Radio.

According to official data, the population could reach 500 animals by 2030 if control measures are not implemented. A scientific study cited by the government recommends removing at least 33 animals per year to achieve a significant reduction.

The plan includes two main methods: euthanasia and translocation. Although Colombia keeps open the possibility of sending some animals abroad, authorities acknowledge that euthanasia will be the primary mechanism due to logistical and sanitary limitations.

“We have a euthanasia protocol that seeks to guarantee technical and ethical criteria to carry it out in a safe and responsible manner,” Vélez said.

The procedure includes chemical and physical euthanasia and requires prior confinement of the animals to minimize risks. The cost per hippo can reach up to $14,000, including sedation, the operation and final disposal through on-site burial, according to Blu Radio reports.

One of the main obstacles to international relocation is the genetic deterioration of the hippos.

All current hippos descend from just four individuals, which has caused inbreeding and malformations.

“The gene pool is too limited, and individuals with mutations have already been found,” Vélez said. “There are visible deformities, such as in the snout, and probably other genetic damage.”

In addition to the genetic component, authorities warn that hippos represent a direct threat to native species, such as manatees and turtles, and also affect water quality in rivers and wetlands.

“This is an invasive species that has a direct impact on water and is significantly affecting biodiversity,” the minister said.

The Colombian government allocated approximately $2 million for the implementation of the control protocols. Authorities expect the next administration, which will take office Aug. 7, to continue their execution to prevent the problem from worsening in the coming years.

U.S. abortion opponents are increasingly frustrated with the lack of action by President Trump’s administration to stem the flow of abortion pills prescribed online that they view as undermining state abortion bans.

A court ruling this week in a lawsuit the Louisiana attorney general brought against Trump’s Food and Drug Administration cast a spotlight on the simmering tension. The judge said the state has a strong case while declining to block telehealth prescriptions to the pill mifepristone for now.

Anti-abortion groups are pushing the FDA to move faster with a review that they hope will result in restrictions on the abortion pill, including blocking its prescribing via telehealth platforms. The administration says the work takes time.

The groups have focused mostly on the health agency and not the Republican president whose three U.S. Supreme Court appointees were instrumental in the 2022 ruling that overturned Roe v. Wade and allowed the state bans in the first place. But the administration’s requests in the Louisiana lawsuit and similar ones elsewhere to delay rulings until it finishes a review have sparked anger for some activists.

“The stall tactics are beyond frustrating,” Kristi Hamrick, a spokesperson for Students for Life of America, said in an interview. Hamrick said the administration could also block the pills from being mailed by changing its interpretation of a 19th century law and enforcing it.

A judge opened the door to pushing the administration

U.S. District Judge David Joseph, who was nominated to the bench by Trump, gave a mixed ruling Tuesday in a case brought by Louisiana Atty. Gen. Liz Murrill and a woman who says her boyfriend coerced her into taking mifepristone to end a pregnancy.

Their overall aim is to roll back FDA rules that have made the pills more accessible. Murrill, like officials in other states that have filed similar lawsuits, contends that the availability of the pills via online providers takes the teeth out of the bans in the 13 states that bar abortion at all stages of pregnancy, with limited exceptions.

Surveys of abortion providers have suggested that its availability through telehealth is a reason the number of abortions in the U.S. has not dropped since the overturn of Roe. While state abortion bans include prohibitions on abortion using the pills, some Democratic-controlled states have adopted laws that seek to protect medical providers who prescribe them over telehealth and mail the pills to states with bans. Those so-called shield laws are being tested through civil and criminal cases.

In the Louisiana case, Joseph declined to grant Murrill’s request to block telehealth prescriptions to the pills while the case moves through the courts. But he said he could do that eventually and the plaintiffs in the case are likely to succeed on the merits of their arguments because the state has demonstrated it’s suffered “irreparable harm.”

He also ordered the FDA to report to him within six months on the status of its review of the drug.

On Wednesday, Murrill filed a notice that she’s taking the case to the U.S. 5th Circuit Court of Appeals in hopes of forcing faster action.

The politics aren’t simple

Family Research Council President Tony Perkins, an influential conservative voice who is also a former Louisiana lawmaker, applauded Murrill’s step.

He said people he meets are often shocked to learn that the number of abortions has not dropped since the 2022 Supreme Court ruling.

“Bewilderment sets in,” he said. “We’re already seeing an enthusiasm gap between the parties. What the Republicans do not need is a dampening of enthusiasm in their base.”

He’s hoping the administration will restrict abortion pills rather than risk losing support from conservative, anti-abortion voters in November’s midterm elections.

Other groups are being more cautions.

Madison LaClare, director of federal government affairs at National Right to Life, said her group trusts the administration to review mifepristone. Marjorie Dannenfelser, president of Susan B. Anthony Pro-Life America, avoided harsh words for the president: “The Trump-Vance administration has an important opportunity right now to prioritize women’s safety,” she said in a statement.

Still, recent electoral results suggest that voters seeking to keep abortion available have the political momentum. Since Roe was overturned, abortion has been on the ballot directly in 17 states. Voters have sided with the abortion-rights side in 14 of those questions.

“There seems to be an emerging consensus in the country that people don’t want to ban abortion,” said Rachel Rebouche, a professor at the University of Texas School of Law who studies abortion.

The FDA says it’s working on it

In a statement Wednesday in response to questions from the Associated Press, the FDA said it’s reviewing the safety of mifepristone, “including the collection of robust and timely data, evaluation of data integrity, and implementation of the analyses, validation, and peer-review.”

After that, the agency said, it will decide whether to make changes to the rules about how the drug can be prescribed.

It said this kind of study can take a year or more to complete by academics but the agency is trying to move faster than that. A spokesperson did not answer questions about when the work began.

Mifepristone has been a political priority for anti-abortion activists and their allies in Congress since Trump returned to office last year. In his January 2025 confirmation hearing, Health and Human Services Secretary Robert F. Kennedy Jr. was repeatedly asked about the drug by Republican lawmakers and said the president had requested a safety review.

Frustration over signs that the FDA isn’t prioritizing curbing abortions flared last fall when the FDA approved an additional generic version of mifepristone.

The drug is most often used for abortion in combination with another drug, misoprostol.

Mifepristone was approved in 2000 as a safe and effective way to end early pregnancies.

Because of rare cases of excessive bleeding, the FDA initially imposed strict limits on who could prescribe and distribute the pill — only specially certified physicians and only after an in-person appointment where the person would receive the pill.

Both those requirements were dropped during the COVID years. At the time, FDA officials said that after more than 20 years of monitoring mifepristone use, and reviewing dozens of studies involving thousands of women, it was clear that women could safely use the pill without direct supervision.

Mulvihill and Perrone write for the Associated Press.

THE drug dealer known as the Ketamine Queen has been sentenced to 15 years behind bars – the maximum term – for her role in Matthew Perry’s tragic death.

Jasveen Sangha, 42, pleaded guilty to five federal charges in September, including distributing ketamine that resulted in the fatal overdose of the Friends star in 2023.

Sangha, a US-British dual national, appeared at the Edward R. Roybal Federal Courthouse in Los Angeles and was slammed by the actor’s stepmom, Debbie Perry, as a “heartless woman”.

In a victim impact statement obtained by The U.S. Sun ahead of the sentencing, Debbie urged a judge to impose the maximum sentence on Sangha.

“The pain you’ve caused to hundreds, maybe thousands, is irreversible,” Debbie wrote in court docs submitted late Tuesday.

“There is no joy… to be found. No light in the window. They won’t be back. That thought comes through our day. Everyday. No escape. You caused this.

NEW ADMISSION

‘Ketamine Queen’ pleads guilty to selling fatal drug dose to Matthew Perry

“You who has talent for business. Enough to make money. Chose the one way that hurts people. How sad for you.

“How will you ever find joy. Have you ever found joy? How sad for you. How sad for you. How sad for us all. We miss him.”

She then begged the court, “Please give this heartless woman the maximum prison sentence so she won’t be able to hurt other families like ours.”

Perry’s mom, Suzanne, and stepdad, Keith Morrison, were seen arriving at court on Wednesday.

During the sentencing hearing, Morrison addressed the court and Sangha.

According to the New York Post, he called Perry a “brilliant and talented man,” and said he should have “had another act.”

“I feel bad for you, Miss Sangha,” he told her. “I don’t hate you. You are a drug dealer.”

Sangha was reportedly dressed in a white jump suit with one ankle shackled.

During an emotional moment, she wiped tears away with tissues from a box placed nearby, according to the outlet.

She also addressed the court, saying she takes full responsibility, adding she had the “rug of life ripped out” from under her.

Sangha had been in custody since August 2024 and was the last of five defendants charged in the investigation to plead guilty.

According to prosecutors, Sangha and a middleman named Erik Fleming sold Perry 25 vials of ketamine, including the fatal dose, for $6,000 in cash just four days before his death.

On the day Perry died, Sangha reportedly messaged Fleming and instructed him to delete their text history, an effort authorities say was meant to cover their tracks.

Prosecutors said in court docs, “She didn’t care and kept selling.

“Defendant’s actions show a cold callousness and disregard for life. She chose profits over people, and her actions have caused immense pain to the victims’ families and loved ones.”

Sangha admitted to one count of maintaining a drug-involved premises, three counts of ketamine distribution, and one count of ketamine distribution resulting in death.

Prosecutors dropped other charges as part of the plea agreement.

Fleming, who obtained the ketamine from Sangha and passed it to Perry’s personal assistant, later pleaded guilty to conspiracy to distribute ketamine resulting in death and faces years in prison.

Sangha operated out of her North Hollywood home, which authorities dubbed the “Sangha Stash House” after federal agents uncovered a large cache of drugs during a raid.

The haul included scores of ketamine vials, crystal meth, cocaine, counterfeit Xanax tablets, and a handgun.

An autopsy confirmed Perry died from acute effects of ketamine and drowning, with toxicology reports indicating multiple doses in the period leading up to his death.

Sangha flaunted her jet-set lifestyle on social media, posting pictures from parties with celebrities, lavish vacations, and designer clothing.

Just days after Perry’s death, she flew to Tokyo, staying at the luxury $1,400-a-night Mandarin Oriental hotel.

Sangha was first arrested in March 2024 on federal drug charges related to her long-running narcotics operation.

Five months later, new federal charges specifically tied to Perry’s overdose were filed; she was taken back into custody and her previous bail was revoked.

Her lawyer, Mark Geragos, announced last year that she would plead guilty, saying she was “taking responsibility for her actions.”

He later told reporters she “feels horrible about all of this” and “has felt horrible since day one.”

In an exclusive jail interview with The Sun before her sentencing, she also said, “I take full responsibility for my actions and the role I played in the events that led to this tragedy. 

“There are no excuses for what I did. I am deeply sorry for the pain I caused, especially to Matthew’s family. 

“Their loss is unimaginable and permanent. 

“I understand that my conduct — operating a drug business and continuing down that path — was reckless, dangerous, and wrong.”

She added, “I can’t undo the past but I can now respect the law. I am determined that my future now reflects accountability and growth.”

Sangha said she is now clean and sober after previous issues with drugs and alcohol and has been undergoing treatment behind bars.

Court documents filed this week show she has also been doing yoga and meditation while locked up at the Los Angeles Metropolitan Detention Center.

Sangha is the third of five people sentenced over Perry’s fatal overdose.

Dr. Salvador Plasencia, one of the doctors who supplied ketamine to Perry in the months before his death, was sentenced to 30 months in prison in December, followed by supervised release.

He shamefully sobbed in court, telling Perry’s mother, Suzanne, and relatives, “I’m just so sorry.”

Dr. Mark Chavez, the second physician involved, received eight months of home confinement and community service.

Two other defendants are still awaiting trial: Kenneth Iwamasa, Perry’s live-in personal assistant, who admitted to helping obtain and administer the ketamine and faces up to 15 years in prison, and Fleming, the middleman.

The five responsible for Matthew Perry’s death

Here are the five individuals allegedly behind Perry’s ketamine overdose.

• “Ketamine Queen of Los Angeles” Jasveen Sangha – Sangha, 42, pleaded guilty in September 2025 to federal charges for supplying the ketamine that caused Matthew Perry’s fatal overdose. Prosecutors say that after Perry’s death, she reportedly searched online, “can ketamine be listed as a cause of death.” She has now been jailed.
• “Dr. P” Dr. Salvador Plasencia – Plasencia, 42, was one of the physicians who illegally supplied ketamine to Perry before his death. He pleaded guilty in mid‑2025 to several federal counts of ketamine distribution. In December 2025, he was sentenced to 30 months in federal prison and fined; he was remanded immediately to begin serving his term.
• Dr. Mark Chavez – Chavez pleaded guilty to conspiracy to distribute ketamine in connection with Perry’s death. In December 2025, he was sentenced to eight months of home confinement, ordered to complete community service, and placed on supervised release.
• Kenneth Iwamasa – Iwamasa, 59, Perry’s live‑in assistant, admitted he obtained and administered ketamine to Perry as part of the scheme. He pleaded guilty to conspiracy to distribute ketamine causing death and is set to be sentenced in April.
• Eric Fleming – Fleming, 54, an intermediary dealer who helped coordinate the flow of ketamine from suppliers to Perry’s assistant, pleaded guilty to conspiracy and distribution charges. He is also set to be sentenced in April.

Court filings show Perry texted Iwamasa, “shoot me up with a big one,” shortly before his death.

Perry, who rose to fame as Chandler Bing on the hit 90s sitcom Friends, was found unconscious in his hot tub in Los Angeles in October 2023 at age 54.

US Attorney Martin Estrada said Perry had relapsed in the fall of 2023, and that “these defendants took advantage to profit for themselves.”

Perry had struggled with decades-long drug and alcohol addiction and became dependent on ketamine during infusion therapy aimed at treating his depression.

If you or someone you know is affected by any of the issues raised in this story, call SAMHSA (Substance Abuse and Mental Health Services Administration) at 1-800-662-HELP (4357)

Woods pleaded not guilty in his driving under the influence case in Florida last week after rolling his SUV.

Prosecutors are seeking Tiger Woods ‘ prescription drug records from a pharmacy, a week after his vehicle crashed in Florida and he was arrested on suspicion of driving under the influence.

Prosecutors in Florida on Tuesday said they planned to issue a subpoena seeking copies of all prescription medication records for the legendary golfer on file at Lewis Pharmacy in Palm Beach, Florida, from the start of the year through the end of last month.

Prosecutors in Martin County, Florida, want the times the prescriptions were filled, the number of pills, the dosage amounts and any instructions that accompanied the pills, such as warnings about driving while taking them, according to documents in an online court docket.

Any objections to the subpoena must be filed with the State Attorney’s Office within 10 days. Neither Lewis Pharmacy nor Woods’ attorney, Doug Duncan, immediately responded to emails seeking comment.

Woods pleaded not guilty in his driving under the influence case in Florida last week, hours after a sheriff’s report said deputies found two pain pills in his pocket and he showed signs of impairment after his SUV clipped a trailer and rolled over on its side.

Woods was travelling at high speeds on a beachside, residential road on Jupiter Island with a 30-mile per hour (nearly 50km per hour) speed limit when the accident occurred, authorities said. The truck had $5,000 in damage, according to an incident report. Woods agreed to a Breathalyzer test that showed no signs of alcohol, but he refused a urine test, authorities said.

Woods said last week that he is stepping away to seek treatment.

It’s the second time Woods has taken a leave following a car crash. In 2009, after his SUV ploughed into a fire hydrant and tree outside his home near Orlando, he took a leave of absence to work on being a better person. That lasted four months, and he returned at the Masters.

He was also in a 2021 car crash in Los Angeles that damaged his right leg so badly he said doctors considered amputation.

April 7 (UPI) — Mexican authorities arrested Remigio Valdez Lao in Cancun, identifying him as a suspected key operator of a criminal network that smuggled migrants into the United States, regional media reported.

The suspect, who goes by “El Milo,” is subject to an extradition order issued by the United States for human trafficking, drug trafficking and international smuggling offenses.

The arrest occurred Monday in one of the main tourist destinations in the Mexican Caribbean after coordinated intelligence work among the Secretariat of the Navy, the Attorney General’s Office, the Army and the National Guard, according to Mexico’s Security Cabinet.

Authorities said “El Milo” served as the operational and financial coordinator of the organization known as the Cuban-American Mafia and oversaw illegal migrant transportation routes and financial flows linked to these operations.

During the operation, agents also detained a second person, identified as Joseline “N,” and seized 38 doses of marijuana and a gray pickup truck.

According to information published by Milenio magazine and confirmed by federal authorities, the suspect was considered a priority target in Quintana Roo. El Milo was immediately transferred to Mexico City to advance the extradition process requested by U.S. authorities.

Judicial reports in the United States, notably from the U.S. Attorney for the Southern District of Florida, identify a structure known as the “Cuban Mafia in Quintana Roo,” dedicated to moving Cuban migrants to the United States through Mexico.

According to those investigations, the organization demanded payments of up to $10,000 per person.

Case files indicate that, if payment were not received, migrants were detained, threatened and forced to contact their relatives to obtain money.

In some cases, members of the group sent photos and videos to pressure payment. If families paid, the victims were released and sent toward the U.S. border to seek asylum.

The U.S. Department of Justice has said that this type of network operates in several countries, including Mexico, Cuba, Spain and the United States, and generates profits through human trafficking and extortion schemes.

Mexico has become a key transit country for migrants, especially Cubans, seeking to reach the U.S. southern border.

The case comes amid intensified bilateral cooperation on security matters.

In January, Mexico extradited 37 inmates linked to criminal organizations to the United States, in what analysts consider a significant step to strengthen cooperation between the two countries.

Authorities have not disclosed additional details about the full structure of the network or the total scope of operations attributed to El Milo, whose legal process will continue in the coming weeks.

Nicolas Maduro appeared in a New York court seeking to dismiss drug trafficking charges, saying sanctions blocking his funds deny him a fair defence. He has pleaded not guilty and faces charges that could carry a life sentence.

NEW YORK — Arkansas Gov. Bill Clinton acknowledged Sunday that he had experimented with marijuana while a 22-year-old student in England in the late 1960s, an admission that could raise doubts about his past candor in answering questions about his personal conduct.

For five years, the 45-year-old Clinton has answered questions about whether he had ever used drugs by saying he had never broken a U.S. law. During a televised debate here with Democratic presidential rival Edmund G. (Jerry) Brown Jr., a questioner for the first time asked Clinton explicitly whether he had ever broken either a state, federal or a foreign drug law.

“When I was in England I experimented with marijuana a time or two,” he answered on the WCBS-TV broadcast, “and I didn’t like it. I didn’t inhale and never tried it again.”

Asked the same series of questions, Brown answered bluntly: “No.”

Clinton’s disclosure, which overshadowed one of the most substantive exchanges of the political season between the two rivals, is hardly unusual for a person of Clinton’s generation. Two of the Democratic presidential candidates in 1988 acknowledged similar behavior. And nothing Clinton said about his use of marijuana contradicted what he had said before.

But his decision until now to fend off drug-use queries with a narrow response, which could mislead voters into thinking he had never used drugs of any kind, was likely to add to concerns of those who regard him as less than straightforward.

Clinton said he did not believe the episode would hurt his candidacy, noting that other politicians had admitted to using marijuana and had suffered no apparent electoral consequences. He defended his previous denials by saying he had seen no need to volunteer a reply to something he had not been directly asked.

“Nobody’s ever asked me that question point blank,” he said, adding: “I said I’ve never broken the drug laws of my country, and that’s the absolute truth.”

It was the second time in a week that Clinton found it necessary to clarify previous statements on drugs.

On Thursday, a Clinton campaign aide, Betsey Wright, volunteered to the Los Angeles Times that the governor had never used cocaine or knowingly been around it.

The Times had contacted Wright to ask about a state police drug investigation in the mid-1980s of Clinton’s half-brother and a political contributor. After answering the questions, Wright said: “I assume from the questions that you were implying guilt by association in a state where everybody is associated. For that reason, when I verified with Gov. Clinton the answers to some of the questions, I asked him the following questions:

“ ‘Bill, have you ever used cocaine?’

“He replied, ‘No.’

“I said, ‘Bill, have you ever been in a room where you were aware there was cocaine?’

“He replied, ‘No.’ ”

When asked Friday why she had posed questions never asked by The Times, Wright said she had heard “rumors” that reporters were trying to place Clinton at parties where cocaine had been used. “I decided it was best to go ahead and put the issue on the table,” she said. (Interviews by The Times with some people said to have been in attendance at those parties have produced no evidence linking Clinton to the drug.)

Later Friday, Clinton called The Times to say that the campaign had not intended to provoke a story quoting him as denying cocaine use. Senior Clinton campaign officials said they feared such a story might be seen by the public as raising yet another question about his personal life.

Clinton’s Sunday acknowledgement of marijuana use while a Rhodes Scholar at Oxford came only three days after Clinton was asked by a member of the editorial board of the New York Daily News whether he had been asked previously about his drug use.

Clinton said that he had been asked such questions, and that his answer had always been that he had never violated a U.S. law.

Clinton campaign officials later described the new admission as an “elaboration” of Clinton’s previous comments and suggested that it and the earlier, narrow denials were merely two ways of looking at the same issue.

“Bill Clinton told the truth at every step of the way,” his chief strategist, James Carville, said. “It’s like the old saying about the guy who’s being sworn into office and he’s asked, ‘Do you swear to tell the truth, the whole truth, and nothing but the truth?’ and he answers, ‘Which one do you want?’ ”

Carville and other senior Clinton aides nevertheless expressed concern that the issue would be given undue prominence and further tar their candidate at a time when polls show that a large number of Democratic voters still harbor questions about Clinton’s personal record.

For his part, however, Brown chose not to make an immediate issue either of Clinton’s marijuana use or his handling of questions about it.

After denying that he had violated any drug laws, Brown demanded of a questioner: “Why don’t you lay off this stuff? What you did 10 or 20 years ago is not really relevant.”

But Brown himself was forced during the debate to respond to a new suggestion of impropriety in a Washington Post story detailing his ties to a company that paid a $400,000 settlement to the federal government after being accused of making exaggerated claims about a product said to help treat AIDS.

Brown, who served on the board of directors of a subsidiary to the company, Costa Mesa-based ICN Pharmaceuticals Inc., until he began his presidential campaign, said he had had “nothing to do” with the episode. He said his position gave him “no responsibility and no contact” with the parent firm.

Clinton did not press the issue during the debate, saying his own experience made him wary of “piling on.” But he suggested later in the day that justice was being done as he told a Bronx audience that “the press is finally starting to look at” a rival he believes has been treated too gently.

Clinton framed his response to the drug question during an era when the issue rose to political prominence.

In 1987, Supreme Court nominee Douglas H. Ginsburg was forced to withdraw his name from nomination after it was learned that he had used marijuana when he was a law-school professor.

But other politicians, including Sen. Albert Gore Jr. of Tennessee and Gov. Bruce Babbitt of Arizona, both 1988 Democratic presidential candidates, acknowledged using marijuana while in college and suffered no apparent political consequences.

Supreme Court Justice Clarence Thomas has also admitted to having used marijuana, but the issue was given only passing attention during his confirmation hearings.

Clinton, by contrast, has steadfastly refused to answer “have you ever” questions about drug use, adultery or other matters of personal conduct on grounds that they are not legitimate subjects of inquiry.

He has said it is legitimate, however, for an officeholder or a candidate to be questioned about violations of law, and has always responded to questions about his drug use by stating that he had adhered to U.S. drug laws.

Earlier in the morning, Clinton delivered what amounted to an impassioned political sermon to the enthusiastic congregation of an African Methodist church in a mostly black neighborhood in Queens.

But faced with continued criticism of his periodic use of an all-white country club to play golf–conduct that Clinton has said was a mistake–his message Sunday was in part a plea for redemption from a black community from which he has so far drawn deep support.

“I have seen myself turned into a cartoon character of an old Southern deal-maker by the tabloids and television in a total denial of my life’s work,” he said.

He told the congregation he had made “a foolish mistake.” And as he cited Scripture later, the congregation joined him in a sympathetic chorus to murmur “those who are without sin should cast the first stone.”

The hourlong debate here between Clinton and Brown, who participated via satellite from Wisconsin, was one of the better illuminations of the differences between the Arkansas moderate and the California populist-liberal.

Again and again, the two candidates clashed on issues ranging from economic policy to capital punishment to labor issues to Middle East strategy.

On economic issues, Brown advanced his proposal to overhaul the current tax systems and replace them with a 13% flat-tax as a “progressive tax” whose simplicity would “jump-start the economy.”

But Clinton, who favors a more conventional middle-class tax cut and an increase on taxes for the wealthy, again derided Brown’s idea as a plan that would benefit only the wealthy and would “triple taxes on the poor and raise taxes on the middle class.”

In answer to a question, Clinton said he favored capital punishment as well as a proposal to accelerate what is now the time-consuming process under which a death-row inmate may appeal his sentence.

But Brown described Clinton’s decision earlier this year to order the execution of a man whose lawyer claimed he was retarded as a “moral abomination.” He contended that the proposal to limit death-penalty appeals was part of a “systematic erosion of civil liberties” and said: “I would oppose it with every ounce that I have.”

Brown said he would favor a five-year moratorium on the manufacture of handguns. But Clinton, while describing himself as an advocate of gun control, said he was unsure whether he could embrace such an approach.

On Israel, Clinton defended what he described as a longstanding U.S. willingness to “wink” at Israeli settlements on the occupied West Bank and criticized the Bush Administration’s recent get-tough policy. But Brown bluntly said he regarded the settlements as “a problem.”

Asked about an issue important to labor unions, the two candidates made clear that their allegiance pulled them in different directions.

Clinton said he would favor placing young people in jobs of all kinds as part of a civilian corps to give them training for the future.

But Brown warned that the low wages paid to such employees would undermine working people and suggested that any such corps be limited to outdoor conservation efforts.

Colombia’s President Gustavo Petro has been named in two separate criminal investigations led by prosecutors in the United States.

The New York Times was the first to report the existence of the two probes on Friday, citing sources familiar with the proceedings.

Media reports indicate that Petro is not personally the target of the investigations, which focus on drug-smuggling in Latin America.

But according to the Times, US attorneys in Brooklyn and Manhattan are looking into whether Petro met with drug traffickers and solicited donations from them for his 2022 presidential campaign. Al Jazeera has not independently verified the Times report.

By Friday afternoon, Petro had issued a statement denying the claims, which threaten to reopen the rift between the US and Colombia.

“In Colombia, there is not a single investigation into my relationship with drug traffickers, for one simple reason: I have never in my life spoken with a drug trafficker,” Petro wrote on the social media platform X.

He added that he told campaign managers to never accept donations from bankers or drug traffickers.

The investigations in the US, he argued, would ultimately exonerate him, and he blamed Colombia’s right-wing opposition for stirring controversy.

“So, the proceedings in the US will help me to dismantle the accusations of the Colombian far right, which is indeed closely linked to Colombian drug traffickers,” Petro said.

Petro has not been charged with any crimes, and the investigations are in their initial stages, according to the Times.

But experts say the timing of the report is significant, as it comes barely two and a half months before Colombia is set to hold a closely watched presidential election on May 31.

“If this would have happened a week before the first round, it would be election interference,” Sergio Guzman, director at Colombia Risk Analysis, a security think tank, told Al Jazeera.

“This seems to be more of a warning that shows how the US could influence the outcome of the election.”

Petro, Colombia’s first left-wing president, is limited to a single term in office, but the election is likely to be a referendum on his four years in office.

It will also be a test for Petro’s Historic Pact coalition, whose candidate, Ivan Cepeda, is currently leading in the polls.

But United States President Donald Trump has repeatedly sought to boost the prospects of right-wing candidates in Latin America. He and Petro have been at loggerheads since Trump returned to office in January 2025.

Their feud came to a head in January after the US attacked Venezuela and abducted its president, Nicolas Maduro.

Shortly afterwards, a reporter asked if the US would take military action against Colombia. Trump replied: “It sounds good to me.”

To cool tensions, Trump and Petro held a call afterwards and agreed to meet.

Petro then visited the White House in early February to mend his often-combative relationship with Trump. While there, the Colombian delegation interacted with their counterparts, including Secretary of Defense Pete Hegseth and Secretary of State Marco Rubio.

Republican Senator Bernie Moreno, a longtime critic of Petro’s government, was also in attendance. Guzman believes the senator’s presence was significant.

“We don’t have a lot of straightforward answers about what were the commitments during that meeting, but Bernie Moreno did say that he wanted Petro not to be as involved in elections,” Guzman told Al Jazeera.

“And guess what? Petro is fully involved in the elections.”

The meeting also addressed collaborative efforts to combat drug trafficking, an issue core to Trump’s foreign policy.

Both presidents walked away from the meeting in good spirits, with Petro sharing a photo signed by Trump that read, “Gustavo – a great honor. I love Colombia.”

But Petro and Trump have long been at odds over how to tamp down on narcotics smuggling.

Colombia, the region’s largest producer of cocaine, has been criticised by the Trump administration for what it sees as soft-on-crime policies, including negotiations with armed groups.

Petro, meanwhile, has denounced the US for its lethal tactics, calling them tantamount to murder.

The US, for instance, has bombed at least 46 alleged drug boats and vessels in the Caribbean Sea and eastern Pacific Ocean. Some of the 159 people killed were Colombian citizens.

The US has also floated the idea of conducting military attacks in Latin America against suspected drug traffickers, and it recently began joint operations against gangs in Ecuador, Colombia’s neighbour.

Analysts say actions like these have Latin American leaders on edge.

Trump’s aggressive manoeuvres suggest that the US president is willing to jeopardise “the sovereignty and peace of every nation” in his campaign against illicit drugs, according to Rodrigo Pombo Cajiao, a constitutional law professor at the Pontificia Universidad Javeriana.

Pombo Cajaio pointed to the US abduction of Venezuelan President Nicolas Maduro on January 3. Maduro was a longtime adversary of Trump, and he is currently being held in prison in New York on drug-related charges.

“Every political leader in the region has been put on notice” after that abduction, Pombo Cajiao said.

“As the world’s leading producer of cocaine, Colombia found itself at high risk of judicial prosecution” from the US, he added.

Currently, Petro’s Historic Pact is leading May’s presidential race. A GAD3 poll released this week suggested Cepeda is ahead in the polls with 35 percent voter approval, ahead of far-right candidate Abelardo de la Espriella, who had 21 percent.

Aden Holloway, the second-leading scorer for the Alabama men’s basketball team, was arrested Monday on a felony drug charge and may not be available for the Crimson Tide during March Madness, pending the university’s investigation into the matter.

Alabama coach Nate Oats said that after he told his players about the situation, the team went out and had “a really good practice” four days ahead of its first-round NCAA tournament game against Hofstra.

“Aden’s one of our guys, and everybody wants to wrap their arms around [him],” Oats said Monday during an appearance on the Crimson Tide Sports Network. “Everybody makes some mistakes in life, but [the players] also understand we’ve got to move on … and the team’s got to go play Friday.

“So I thought we did a good job of that this morning, kind of addressing the situation, what we currently knew at the time, and got our guys focused on practice.”

Holloway’s arrest came after the West Alabama Narcotics Task Force searched a residence near campus and “recovered more than a pound of marijuana, paraphernalia and cash,” the Tuscaloosa Police Department said.

The 21-year-old player is facing a first-degree charge of marijuana possession, not for personal use, which is a Class C felony and carries a penalty of up to 10 years in prison and a maximum fine of $15,000.

Police said Holloway also will be charged with failure to affix a tax stamp, another felony. Holloway was taken to jail shortly before 10 a.m. and was released less than an hour later on a $5,000 bond.

Alabama said in a statement Monday: “The University is aware of the allegations and is working to gather more information. The student has been removed from campus pending further investigation by the UA Office of Student Conduct.”

Oats said players need to be held accountable if they fail to meet the standards set by the program.

“So, you know, we had to suspend [Holloway] pending the investigation by the UA office of student conduct,” Oats said. “And we’re certainly disappointed in his behavior. But that being said, we still love him. He’s still our guy. We’re helping him get the help he needs, and we’re going to continue to help him whatever way we can.”

Meanwhile, the Crimson Tide, the No. 4 seed in the Midwest Region, continues to prepare to face 13th-seeded Hofstra on Friday without a player who averages 16.8 points a game. Sophomore guard Labaron Philon Jr. leads the team with 21.7 points a game, and sixth-year senior Latrell Wrightsell Jr. is averaging 12.8 points.

“I did tell our team, this team more than any team I’ve ever coached is better equipped to handle a situation like this,” Oats said. “I don’t know how many games we went into where we had a game time decision. Guy goes, warms up, and we got to decide whether he’s going to play or not an hour before the game. … We’ve won plenty of games with guys not available, so our guys will be ready to go against Hofstra.”

The Associated Press contributed to this report.

Rescuers are combing through the wreckage of a drug rehabilitation centre in Kabul where Afghan officials say a Pakistani strike has killed at least 400 people.